Disease Management < Disease Models, Animal < Disease Outbreaks

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 152.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000005 (1998)	A. Hadj Tahar [Canada] ; P J Bédard	[Understanding and treating levodopa-induced dyskinesias].
000029 (1999)	C R Honey [Canada] ; H. Shen	Immunosuppression for neural xenografts: a comparison of cyclosporin and anti-CD25 monoclonal antibody.
000031 (1999)	M O Hebb [Canada] ; H A Robertson	Motor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases.
000084 (2000)	K A Baker [Canada] ; M. Hong ; D. Sadi ; I. Mendez	Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
000085 (2000)	I. Mendez [Canada] ; K A Baker ; M. Hong	Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease.
000094 (2000)	E F Field [Canada] ; I Q Whishaw ; S M Pellis	Sex differences in catalepsy: evidence for hormone-dependent postural mechanisms in haloperidol-treated rats.
000111 (2000)	G. Clarke [Canada] ; R A Collins ; B R Leavitt ; D F Andrews ; M R Hayden ; C J Lumsden ; R R Mcinnes	A one-hit model of cell death in inherited neuronal degenerations.
000117 (2000)	M. Goulet [Canada] ; R. Grondin ; M. Morissette ; S. Maltais ; P. Falardeau ; P J Bédard ; T. Di Paolo	Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
000155 (2001)	F. Calon [Canada] ; N. Lavertu ; A M Lemieux ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo	Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
000168 (2001)	C. Zhang [Canada] ; J P Steiner ; G S Hamilton ; T P Hicks ; M O Poulter	Regeneration of dopaminergic function in 6-hydroxydopamine-lesioned rats by neuroimmunophilin ligand treatment.
000237 (2002)	Ian Q. Whishaw [Canada] ; Oksana Suchowersky ; Leigh Davis ; Justyna Sarna ; Gerlinde A. Metz ; Sergio M. Pellis	Impairment of pronation, supination, and body co-ordination in reach-to-grasp tasks in human Parkinson's disease (PD) reveals homology to deficits in animal models.
000254 (2002)	Arun Chander Ramachandran [Canada] ; Lynsey Erin Bartlett ; Ivar Marcelo Mendez	A multiple target neural transplantation strategy for Parkinson's disease.
000260 (2003)	A. Hadj Tahar [Canada] ; R. Grondin ; L. Grégoire ; F. Calon ; T. Di Paolo ; P J Bédard	New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
000273 (2003)	Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. Whishaw	A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
000305 (2003)	Stephen J. Crocker [Canada] ; Patrice D. Smith ; Vernice Jackson-Lewis ; Wiplore R. Lamba ; Shawn P. Hayley ; Erich Grimm ; Steve M. Callaghan ; Ruth S. Slack ; Edon Melloni ; Serge Przedborski ; George S. Robertson ; Hymie Anisman ; Zul Merali ; David S. Park	Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease.
000316 (2003)	Clement Hamani [Canada] ; Andres M. Lozano	Physiology and pathophysiology of Parkinson's disease.
000317 (2002)	Andres M. Lozano [Canada] ; Jonathan Dostrovsky ; Robert Chen ; Peter Ashby	Deep brain stimulation for Parkinson's disease: disrupting the disruption.
000326 (2003)	A Jon Stoessl [Canada]	Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
000365 (2003)	Patrice D. Smith [Canada] ; Stephen J. Crocker [Canada] ; Vernice Jackson-Lewis ; Kelly L. Jordan-Sciutto [États-Unis] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Michael J. O'Hare [Canada] ; Steven Callaghan [Canada] ; Ruth S. Slack [Canada] ; Serge Przedborski [États-Unis] ; Hymie Anisman [Canada] ; David S. Park [Canada]	Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease
000367 (2003)	C A Shaw [Canada] ; J M B. Wilson	Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models.
000378 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. Bédard	Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Disease Models, Animal" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Disease Models, Animal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Disease Models, Animal
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022